Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease

About this update from Ventripoint Diagnostics Ltd.

Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease (TheNewswire)   Collaboration inspired by families' lived experiences aims to reduce barriers to advanced cardiac imaging and ensure no parent faces impossible decisions when seeking answers about their child's heart.     Toronto, Ontario – TheNewswire – June 26, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a pioneer in advanced cardiac imaging, today announced a strategic collaboration with Ollie Hinkle Heart Foundation (OHHF) to expand access to AI-powered cardiac imaging and clinical decision-support technology for children and adults living with congenital and childhood-onset heart disease.   The collaboration combines Ventripoint's AI-powered VMS+™ cardiac imaging platform with OHHF's Take Heart Collective Impact Model, which brings together healthcare providers, innovators, researchers, patients, families, and social partners—including Jovie's Joy and Ella's Umbrella—to accelerate innovation and improve outcomes for children and families impacted by heart disease.   As part of the collaboration, OHHF will initially provide financial support enabling the placement of two VMS+™ systems within its healthcare partner network and further opportunities for education, advocacy, research, technology adoption, and community engagement initiatives.   Ventripoint's VMS+™ platform uses artificial intelligence and advanced cardiac modeling to provide clinicians with highly accurate measurements of heart structure and function from a standard echocardiogram. By delivering sophisticated cardiac insights in a more accessible and efficient way, VMS+™  enhances clinical decision-making, supports ongoing patient monitoring, and expands access to advanced cardiac assessment across a wide range of heart conditions.    "Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging," said Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint Diagnostics. "Ollie Hinkle Heart Foundation has become a respected leader in bringing together families, clinicians, healthcare systems, and innovators to solve com...

View stock analysis, news, and events for Ventripoint Diagnostics Ltd.